U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 80

1.
Diverse roles of UBE2T in cancer (Review)
Nengqian Ma, Zhangzhan Li, Jingting Yan, Xianrong Liu, Liyan He, Ruijie Xie, Xianzhou Lu
Oncol Rep. 2023 Apr; 49(4): 69. Published online 2023 Feb 22. doi: 10.3892/or.2023.8506
PMCID:
PMC9996685
ArticlePDF–3.2M
2.
Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
Kui Cao, Xiaodong Ling, Xiangyu Jiang, Jianqun Ma, Jinhong Zhu
Respir Res. 2022; 23: 306. Published online 2022 Nov 10. doi: 10.1186/s12931-022-02226-z
PMCID:
PMC9650835
ArticlePDF–8.6M
3.
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer
Ping Cui, Hao Li, Can Wang, Yuan Liu, Mengjun Zhang, Yue Yin, Zhenxing Sun, Yiru Wang, Xiuwei Chen
J Ovarian Res. 2022; 15: 103. Published online 2022 Sep 10. doi: 10.1186/s13048-022-01034-9
PMCID:
PMC9464398
ArticlePDF–6.3M
4.
UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer
Wei Huang, Hongyan Huang, Yuzhen Xiao, Lei Wang, Tingting Zhang, Xiaoling Fang, Xiaomeng Xia
Cell Cycle. 2022; 21(8): 780–791. Published online 2022 Feb 7. doi: 10.1080/15384101.2022.2031426
PMCID:
PMC8973388
ArticlePDF–4.0M
5.
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, Zhihong Zhang, Li Liu, Dehua Wu, Jingyuan Sun
Cell Death Dis. 2022 Feb; 13(2): 154. Published online 2022 Feb 15. doi: 10.1038/s41419-022-04596-0
PMCID:
PMC8847552
ArticlePDF–6.5M
6.
UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
Jinhong Zhu, Haijiao Ao, Mingdong Liu, Kui Cao, Jianqun Ma
J Transl Med. 2021; 19: 374. Published online 2021 Aug 30. doi: 10.1186/s12967-021-03056-1
PMCID:
PMC8407090
ArticlePDF–3.2M
7.
UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
Xiaoyuan Wang, Yang Liu, Xue Leng, Kui Cao, Wentao Sun, Jinhong Zhu, Jianqun Ma
Pathol Oncol Res. 2021; 27: 632531. Published online 2021 Apr 9. doi: 10.3389/pore.2021.632531
PMCID:
PMC8262217
ArticlePDF–4.9M
8.
A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype
Laura Schultz-Rogers, Francis P. Lach, Kimberly A. Rickman, Alejandro Ferrer, Abhishek A. Mangaonkar, Tanya L. Schwab, Christopher T. Schmitz, Karl J. Clark, Nikita R. Dsouza, Michael T. Zimmermann, Mark Litzow, Nicole Jacobi, Eric W. Klee, Agata Smogorzewska, Mrinal M. Patnaik
Haematologica. 2021 Apr 1; 106(4): 1188–1192. Published online 2021 Apr 1. doi: 10.3324/haematol.2020.259275
PMCID:
PMC8018101
ArticlePDF–1.3M
9.
Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma
Xuemiao Zhao, Wei Weng, Miao Jin, Sunjian Li, Qingwei Chen, Bingrong Li, Zhou Zhou, Chuanqiang Lan, Yunjun Yang
Med Sci Monit. 2021; 27: e929023-1–e929023-11. Prepublished online 2020 Dec 31. Published online 2021 Mar 4. doi: 10.12659/MSM.929023
PMCID:
PMC7941760
ArticlePDF–2.6M
10.
Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway
Yu Wang, Hui Leng, Hui Chen, Lei Wang, Nan Jiang, Xin Huo, Bin Yu
Oncol Res. 2016; 24(5): 361–369. Published online 2016 Sep 14. doi: 10.3727/096504016X14685034103310
PMCID:
PMC7838603
ArticlePDF–6.9M
11.
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation
Jingyuan Sun, Zhenru Zhu, Wenwen Li, Mengying Shen, Chuanhui Cao, Qingcan Sun, Zeqin Guo, Li Liu, Dehua Wu
J Exp Clin Cancer Res. 2020; 39: 222. Published online 2020 Oct 21. doi: 10.1186/s13046-020-01734-4
PMCID:
PMC7576867
ArticlePDF–8.3M
12.
High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
Weilong Zhang, Ye Zhang, Zuozhen Yang, Xiaoni Liu, Ping Yang, Jing Wang, Kai Hu, Xue He, Xiuru Zhang, Hongmei Jing
Cancer Gene Ther. 2019; 26(11): 347–355. Published online 2019 Jan 9. doi: 10.1038/s41417-018-0070-x
PMCID:
PMC6892417
ArticlePDF–1.6M
13.
Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis
Jian Guo, Mu Wang, Jun-Ping Wang, Chang-Xin Wu
World J Gastroenterol. 2019 Nov 21; 25(43): 6386–6403. Published online 2019 Nov 21. doi: 10.3748/wjg.v25.i43.6386
PMCID:
PMC6881511
ArticlePDF–10M
14.
UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma
Peng Hao, Bo Kang, Yapeng Li, Wenqi Hao, Feihong Ma
Mol Med Rep. 2019 Aug; 20(2): 1212–1220. Published online 2019 Jun 3. doi: 10.3892/mmr.2019.10322
PMCID:
PMC6625406
ArticlePDF–752K
15.
Deficiency of the Fanconi anemia E2 ubiqitin conjugase UBE2T only partially abrogates Alu-mediated recombination in a new model of homology dependent recombination
Todd W Lewis, Joanna R Barthelemy, Elizabeth L Virts, Felicia M Kennedy, Rujuta Y Gadgil, Constanze Wiek, Rene M Linka, Feng Zhang, Paul R Andreassen, Helmut Hanenberg, Michael Leffak
Nucleic Acids Res. 2019 Apr 23; 47(7): 3503–3520. Published online 2019 Feb 1. doi: 10.1093/nar/gkz026
PMCID:
PMC6468168
ArticlePDF–3.4M
16.
UBE2T knockdown inhibits gastric cancer progression
Changjiang Luo, Yunyi Yao, Zeyuan Yu, Huinian Zhou, Lingyun Guo, Junqiang Zhang, Hongtai Cao, Genyuan Zhang, Yumin Li, Zuoyi Jiao
Oncotarget. 2017 May 16; 8(20): 32639–32654. Published online 2017 Mar 6. doi: 10.18632/oncotarget.15947
Correction in:
Oncotarget. 2023; 14: 188–189.
PMCID:
PMC5464816
ArticlePDF–4.7M
17.
Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening
Francesca E. Morreale, Alessio Bortoluzzi, Viduth K. Chaugule, Connor Arkinson, Helen Walden, Alessio Ciulli
J Med Chem. 2017 May 11; 60(9): 4093–4098. Published online 2017 Apr 24. doi: 10.1021/acs.jmedchem.7b00147
PMCID:
PMC5441753
ArticlePDF–3.8M
18.
UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway
Wei Hu, Lushan Xiao, Chuanhui Cao, Shengni Hua, Dehua Wu
Oncotarget. 2016 Mar 22; 7(12): 15161–15172. Published online 2016 Mar 1. doi: 10.18632/oncotarget.7805
PMCID:
PMC4924777
ArticlePDF–4.9M
19.
Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer
Mingxin Wen, Yongwon Kwon, Yongsheng Wang, Jian-Hua Mao, Guangwei Wei
Oncotarget. 2015 Sep 22; 6(28): 25226–25239. Published online 2015 Jul 30. doi: 10.18632/oncotarget.4712
PMCID:
PMC4694827
ArticlePDF–6.1M
20.
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia
Elizabeth L. Virts, Anna Jankowska, Craig Mackay, Marcel F. Glaas, Constanze Wiek, Stephanie L. Kelich, Nadine Lottmann, Felicia M. Kennedy, Christophe Marchal, Erik Lehnert, Rüdiger E. Scharf, Carlo Dufour, Marina Lanciotti, Piero Farruggia, Alessandra Santoro, Süreyya Savasan, Kathrin Scheckenbach, Jörg Schipper, Martin Wagenmann, Todd Lewis, Michael Leffak, Janice L. Farlow, Tatiana M. Foroud, Ellen Honisch, Dieter Niederacher, Sujata C. Chakraborty, Gail H. Vance, Dmitry Pruss, Kirsten M. Timms, Jerry S. Lanchbury, Arno F. Alpi, Helmut Hanenberg
Hum Mol Genet. 2015 Sep 15; 24(18): 5093–5108. Published online 2015 Jun 17. doi: 10.1093/hmg/ddv227
PMCID:
PMC4550815
ArticlePDF–978K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center